Bibliography
- SAWITZKI B, KINGSLEY CI, OLIVEIRA V et al.: IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. (2005) 201(12):1925-1935.
- OCHANDO JC, HOMMA C, YANG Y et al.: Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. (2006) 7(6):652-662.
- MUNN DH, ZHOU M, ATTWOOD JT et al.: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science (1998) 281(5380):1191-1193.
- TAN PH, BEUTELSPACHER SC, WANG YH et al.: Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol. Ther. (2005) 11(5):790-800.
- BEUTELSPACHER SC, TAN PH, MCCLURE MO et al.: Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am. J. Transplant. (2006) 6(6):1320-1330.
- TAN PH, YATES JB, XUE SA et al.: Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression. Blood (2005) 106(9):2936-2943.
- TAN PH, SAGOO P, CHAN C et al.: Inhibition of NF-{kappa}B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J. Immunol. (2005) 174(12):7633-7644.
- BUCKLAND M, JAGO CB, FAZEKASOVA H et al.: Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells. Am. J. Transplant. (2006) 6(9):2046-2059.
- MIRENDA V, MILLINGTON O, LECHLER RI et al.: Tolerant T cells display impaired trafficking ability. Eur. J. Immunol. (2005) 35(7):2146-2156.
- LECHLER RI, SYKES M, THOMSON AW, TURKA LA: Organ transplantation-how much of the promise has been realized? Nat. Med. (2005) 11(6):605-613.
- MORELLI AE, LARREGINA AT, SHUFESKY WJ et al.: Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood (2004) 104(10):3257-3266.
- STANISLAWSKI T, VOSS RH, LOTZ C et al.: Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat. Immunol. (2001) 2(10):962-970.